Ramsay Health Care Limited (ASX:RHC) is focused on improving the performance of its Australian hospital Business while continuing to invest in clinical innovation, priority therapeutic areas and capacity utilisation. In FY2026, the group reported improved Earnings across all regions, while management highlighted funding conditions and Revenue indexation as important factors influencing future performance.

A Recovery Built on Operational Improvement

For the twelve months to 30 June 2026, Ramsay reported underlying net profit after tax after non-controlling interests of $364.1 million, up 19.3% on the prior year, or 22.9% on a constant-currency basis. Australian underlying EBIT rose 11.2% to $639.8 million, supported by higher activity, improved theatre utilisation, higher acuity, improved private Health Insurance indexation and cost management.

The Australian business recorded activity growth of 3.3%, while visiting medical officers increased by 3.3% and theatre utilisation improved by approximately 90 basis points. Ramsay also highlighted improved revenue indexation relative to cost indexation as part of the performance improvement in Australia.

Group Capital Expenditure was $729 million on a constant-currency basis, below the company’s revised range, with growth and development spending focused on Australia and procedural capacity.

Why Funding Conditions Matter

Funding remains an important issue for Ramsay’s Australian operations. The company said improved private health insurance indexation contributed to the FY2026 result, while changes in private health insurer indexation and pricing remain among the factors that could affect future performance.

Ramsay’s Australian result was also partly offset by the new funding mechanism at Joondalup Health Campus, which had an approximately $26 million net impact after operational mitigation.

For FY2027, Ramsay is targeting further EBIT growth and Margin expansion in Australia through activity growth, improved capacity utilisation, revenue indexation in line with cost indexation and continued operational improvement. The company also expects an additional $10 million to $15 million of operating Investment in information technology, technology and transformation.

Ramsay Santé Separation Reshapes the Portfolio

Ramsay is also progressing the proposed separation of Ramsay Santé, subject to Shareholder approval. The company said the proposed transaction would simplify its portfolio and allow management to focus more closely on the transformation and growth potential of the Australian hospital business.

The company expects the Ramsay Santé separation to be completed in 2026, subject to a shareholder vote in November. If approved, Ramsay Santé would be reported as a discontinued business in Ramsay’s FY2027 reporting.

The separation comes as Ramsay Santé continues to face funding pressure in parts of Europe. Ramsay reported that French hospital Tariff indexation remained inadequate relative to cost inflation, even as performance improvement initiatives helped offset some of the pressure.

The Key Issue Going Forward

Ramsay’s FY2026 results show that its Australian hospital business is improving through higher activity, better utilisation and cost management. However, future investment capacity remains linked to the balance between revenue indexation, operating costs and funding arrangements.

For FY2027, the group expects EBIT growth and margin improvement across its Funding Group, with Australia remaining a major focus. Ramsay has also guided to total Funding Group capital expenditure of $480 million to $520 million as it continues investing across its portfolio.